Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
13.38
-0.03 (-0.22%)
Jul 21, 2026, 3:04 PM CST
SHE:002755 Market Cap
SHE:002755 has a market cap or net worth of 12.42 billion as of July 21, 2026. Its market cap has decreased by -48.16% in one year.
Market Cap
12.42B
Enterprise Value
10.02B
Revenue
1.75B
Ranking
n/a
PE Ratio
47.88
Stock Price
13.38
ChartMarket Cap Chart
Since January 2, 2019, SHE:002755's market cap has increased from 9.84B to 12.42B, an increase of 26.23%. That is a compound annual growth rate of 3.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 12.42B | -18.06% |
| Dec 31, 2025 | 15.16B | 28.48% |
| Dec 31, 2024 | 11.80B | 17.47% |
| Dec 29, 2023 | 10.04B | 36.27% |
| Dec 30, 2022 | 7.37B | -37.63% |
| Dec 31, 2021 | 11.82B | -2.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harbin Pharmaceutical Group | 13.42B |
| Zhejiang Jiuzhou Pharmaceutical | 13.30B |
| Zhejiang Hisun Pharmaceutical | 13.11B |
| Shenzhen Hepalink Pharmaceutical Group | 13.00B |
| Nanjing King-Friend Biochemical Pharmaceutical | 12.75B |
| Henan Lingrui Pharmaceutical | 12.61B |
| Guobang Pharma | 12.52B |
| Shenzhen Chipscreen Biosciences | 12.38B |